Pemetrexed for Injection recalled due to lack of sterility assurance
Reliance Life Sciences is recalling Pemetrexed for Injection 500mg/Vial nationwide due to lack of sterility assurance. The affected product may not meet required sterility standards for intravenous use.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterile injectable drug with a lack of sterility assurance. Intravenous medications that do not meet sterility standards pose serious risk of infection and other adverse health consequences, meeting the Severe classification threshold.
Plain-English summary
Reliance Life Sciences Private Limited is recalling Pemetrexed for Injection 500mg/Vial (NDC 70069-0835-01), manufactured for Somerset Therapeutics, LLC, due to lack of sterility assurance. Approximately 5,020 vials have been distributed nationwide in the USA.
The affected lots are: RPTH0125A (expiry January 31, 2028), RPTH0225A (expiry January 31, 2028), RPTH0325A (expiry January 31, 2028), and RPTH0725A (expiry April 30, 2028). Each carton contains one 50 mL single-dose vial for intravenous use only.
Healthcare providers and patients who have received this product should contact their healthcare provider or pharmacy. Patients should not use the recalled product and should seek medical guidance regarding their current therapy. The product is prescription-only and should only be handled by licensed healthcare professionals.
The recalled product
- Product
- Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
- Manufacturer
- Reliance Life Sciences Private Limited
- Category
- Drug — Injectable / Intravenous
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot
- expiry: RPTH0125A Jan 31
- 2028
- RPTH0225A Jan 31
- RPTH0325A Jan 31
- RPTH0725A Apr 30
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateGasco Isopropyl Alcohol 70% recalled for subpotent drug content
FDA (Drugs) · 2026-07-15
- ModerateGasco Isopropyl Alcohol 70% recalled nationwide for subpotency
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateDrogueria San Juan Isopropyl Alcohol 70% recalled for subpotency
FDA (Drugs) · 2026-07-15